Reoperation for recurrent/persistent well-differentiated thyroid cancer

Otolaryngologic Clinics of North America

Volumn 43, Issue 2, 2010, Pages 353-363

  Pai, Sara I ^a,b   Tufano, Ralph P ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Algorithm; Recurrent persistent papillary thyroid cancer; Reoperative surgery; Well differentiated thyroid cancer

Indexed keywords

ASPIRATION BIOPSY; CANCER RECURRENCE; CANCER SURGERY; CERVICAL LYMPH NODE; HUMAN; HYPOPARATHYROIDISM; LYMPH NODE DISSECTION; MORBIDITY; NERVE INJURY; OVERALL SURVIVAL; PREOPERATIVE PERIOD; RECURRENT LARYNGEAL NERVE; REOPERATION; REVIEW; STERNOCLEIDOMASTOID MUSCLE; SURGICAL APPROACH; SURGICAL TECHNIQUE; THYROID CANCER; WELL DIFFERENTIATED THYROID CANCER;

ADENOCARCINOMA, FOLLICULAR; ALGORITHMS; CARCINOMA, MEDULLARY; DIAGNOSTIC IMAGING; HUMANS; LYMPH NODE EXCISION; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PARATHYROID GLANDS; PROGNOSIS; RECURRENT LARYNGEAL NERVE; REOPERATION; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 77953276063     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2010.02.004     Document Type: Review

References (46)

1. Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006, 295:2164.
2. Surveillance, Epidemiology, and End Results (SEER) Program. April 2006. SEER State Database: Incidence-SEER 9 Regs Public-Use, Nov 2005 Sub (1973-2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released. Available at: Accessed November 20, 2009. http://www.seer.cancer.gov.
3. Cooper D.S., Doherty G.M., Haugen B.R., et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19(1):1167-1214.
4. Farrag T.Y., Samlan R.A., Lin F.R., et al. The utility of evaluating true vocal fold motion before thyroid surgery. Laryngoscope 2006, 116(20):235-238.
5. Randolph G.W., Kamani D. The importance of pre-operative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy. Surgery 2006, 139(3):357-362.
6. Farrag T.Y., Agrawal N., Sheth S., et al. Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma. Head Neck 2007, 29(12):1069-1074.
7. Robbins K.T., Shaha A.R., Medina J.E., et al. Committee for neck dissection classification, American Head and Neck Society. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 2008, 134(5):536-538.
8. Arturi F., Russo D., Giuffrida D., et al. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 1997, 82:1638-1641.
9. Machens A., Hinze R., Thomusch O., et al. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002, 26:22-28.
10. Coburn M., Teates D., Wanebo J.H. Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131). Ann Surg 1994, 219:587-593.
11. Schlumberger M.J. Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status. J Endocrinol Invest 1999, 22:3-7.
12. Grant C.S., Hay I.D., Gough I.R., et al. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important?. Surgery 1988, 104:954-962.
13. Mazzaferri E.L., Jhiang S.M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994, 97:418-428.
14. Lundgren C.I., Hall P., Dickman P.W., et al. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 2006, 106:524-531.
15. Lin J.D., Liou M.J., Chao T.C., et al. Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases. Endocr Relat Cancer 1999, 6:109-115.
16. Sugitani I., Kasai N., Fujimoto Y., et al. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004, 135:139-148.
17. Kouvaraki M.A., Lee J.E., Shapiro S.E., et al. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 2004, 136:1183-1191.
18. Simon D., Goretzki P.E., Witte J., et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 1996, 20:860-866.
19. Carty S.E., Cooper D.S., Doherty G.M., et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. The American Thyroid Association Surgery Working Group with Participation from the American Association of Endocrine Surgeons, American Academy of Otolaryngology-Head and Neck Surgery and American Head and Neck Society. Thyroid 2009, 19(11):1153-1158.
20. Scheumann G.F., Gimm O., Wegener G., et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994, 18:559-568.
21. Uchino S., Noguchi S., Yamashita H., et al. Modified radical neck dissection for differentiated thyroid cancer: operative technique. World J Surg 2004, 28:1199-1203.
22. Uruno T., Miyauchi A., Shimizu K., et al. Prognosis after reoperation for local recurrence of papillary thyroid carcinoma. Surg Today 2004, 34:891-895.
23. Kohara N., Furui J., Tomioka T., et al. Surgical treatment of recurrent thyroid carcinoma after primary resection. Nippon Geka Gakkai Zasshi 1993, 94:847-852.
24. Sivanandan R., Soo K.C. Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg 2001, 88:1241-1244.
25. Kupferman M.E., Patterson M., Mandel S.J., et al. Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2004, 130:857-860.
26. Caron N.R., Tan Y.Y., Ogilvie J.B., et al. Selective modified radical neck dissection for papillary thyroid cancer-is level I, II and V dissection always necessary?. World J Surg 2006, 30:833-840.
27. Lee Y.H., Lee N.J., Kim J.H., et al. US diagnosis of cervical recurrence in patients operated on thyroid cancer: sonographic features and clinical significance. Auris Nasus Larynx 2007, 34:213-219.
28. Roh J.L., Park J.Y., Rha K.S., et al. Is central neck dissection necessary for the treatment of lateral cervical nodal recurrence of papillary thyroid carcinoma?. Head Neck 2007, 29:901-906.
29. Farrag T., Lin F., Brownlee N., et al. Is routine dissection of level IIB and VA necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels. World J Surg 2009, 33:1680-1683.
30. Alvardo R., Sywak M.S., Delbridge L., et al. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: is there added morbidity?. Surgery 2009, 145:514-518.
31. Pai S.I., Tufano R.P. Central compartment neck dissection for thyroid cancer: technical considerations. ORL J Otorhinolaryngol Relat Spec 2008, 70(5):292-297.
32. Shaha A.R., Jaffe B.M. Parathyroid preservation during thyroid surgery. Am J Otol 1998, 109:568-574.
33. Wingert D.J., Friesen S.R., Illiopoulos J.I., et al. Post-thyroidectomy hypocalcemia: incidence and risk factors. Am J Surg 1986, 152:606-610.
34. Levin K.E., Clark A.H., Duh Q.Y., et al. Reoperative thyroid surgery. Surgery 1992, 111:604-607.
35. Chao T.C., Jeng L.B., Lin J.D., et al. Reoperative thyroid surgery. World J Surg 1997, 21:644-647.
36. Moley J.F., Lairmore T.C., Doherty G.M., et al. Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations. Surgery 1999, 125:673-679.
37. Kasemsuwan L., Nubthuenetr S. Recurrent laryngeal nerve paralysis: a complication of thyroidectomy. J Otolaryngol 1997, 26:365-367.
38. Wagner H.E., Seiler C. Recurrent laryngeal nerve palsy after thyroid gland surgery. Br J Surg 1994, 81:226-228.
39. Tisell L., Hansson G., Jansson S., et al. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986, 99:60-66.
40. Goretzki P., Simon D., Frilling A., et al. Surgical reintervention for differentiated thyroid cancer. Br J Surg 1993, 80:1009-1012.
41. Patou C.A., Norton J.A., Brennan M.F. Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J Surg 1998, 22:718-724.
42. Dralle H., Sekulla C., Haerting J., et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 2004, 136:1310-1322.
43. Randolph G.W. Surgical anatomy of the recurrent laryngeal nerve. Surgery of the thyroid and parathyroid glands 2003, 300-342. WB Saunders, Philadelphia. G.W. Randolph (Ed.).
44. Snyder S.K., Hendricks J.C. Intraoperative neurophysiology testing of the recurrent laryngeal nerve: plaudits and pitfalls. Surgery 2005, 138:1183-1192.
45. Dralle H., Sekulla C., Lorenz K., et al. Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery. World J Surg 2008, 32:1358-1366.
46. Moley J.F., Wells S.A., Dilley W.G., et al. Reoperation for recurrent or persistent medullary thyroid cancer. Surgery 1993, 114:1090-1095.